1,2-Propanediol,3-(4-chlorophenoxy)- cas no:104-29-0
Synonyms: 1,2-Propanediol,3-(p-chlorophenoxy)- (6CI,7CI,8CI);3-(4-Chlorophenoxy)-1,2-propanediol;3-(p-Chlorophenoxy)propane-1,2-diol;Adermykon;Chlorphenesin;Demykon;ElestabCPN;Gecophen;Glycerol a-p-chlorophenyl ether;Mycil;NSC 6401;p-Chlorophenyl glyceryl ether;p-Chlorophenyl-a-glycerylether;p-Chlorphenesin;
Name1,2-Propanediol,3-(4-chlorophenoxy)-
CAS104-29-0
Synonyms1,2-Propanediol,3-(p-chlorophenoxy)- (6CI,7CI,8CI);3-(4-Chlorophenoxy)-1,2-propanediol;3-(p-Chlorophenoxy)propane-1,2-diol;Adermykon;Chlorphenesin;Demykon;ElestabCPN;Gecophen;Glycerol a-p-chlorophenyl ether;Mycil;NSC 6401;p-Chlorophenyl glyceryl ether;p-Chlorophenyl-a-glycerylether;p-Chlorphenesin;
EINECS(EC#)203-192-6
Molecular FormulaC9H11ClO3
Molecular Weight202.64
Appearancewhite to off-white crystalline powder
refractive index1.565
Hazard UN
NO.
Risk R20/21/22
Safety
Risk Statements: 20/21/22
R20/21/22: 1,2-Propanediol,3-(4-chlorophenoxy)- (CAS NO.104-29-0 ) is harmful by inhalation, in contact with skin and if swallowed.
Safety Statements: 26-36
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36: Wear suitable protective clothing.
| Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
| mouse |
LD50 |
subcutaneous |
911mg/kg (911mg/kg) |
PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)
BEHAVIORAL: MUSCLE WEAKNESS
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
Journal of Pharmacology and Experimental Therapeutics. Vol. 93, Pg. 470, 1948. |
